IDEXX Laboratories Inc (0J8P.L)

Healthcare | Medical Equipment Services
Income Statement (Quarterly) 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue 1,105,239,000 1,109,457,000 998,427,000 954,288,000
Cost of Revenue 421,885,000 414,725,000 375,048,000 383,628,000
Gross Profit 683,354,000 694,732,000 623,379,000 570,660,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 265,093,000 259,788,000 247,784,000 251,245,000
Operating Expenses 328,508,000 321,686,000 306,845,000 308,974,000
Operating Income 354,846,000 373,046,000 316,534,000 261,686,000
Interest Expense -46,206,000 11,321,000 7,666,000 7,498,000
Income Before Tax 344,771,000 362,352,000 310,084,000 256,387,000
Income Tax Expense 70,161,000 68,363,000 67,407,000 40,238,000
Net Income 274,610,000 293,989,000 242,677,000 216,149,000
Per Share
EPS -6.64 3.66 2.98 2.63
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 3,897,504,000 3,660,953,000 3,367,324,000
Cost of Revenue 1,518,577,000 1,470,983,000 1,388,719,000
Gross Profit 2,378,927,000 2,189,970,000 1,978,605,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 1,030,798,000 901,891,000 849,553,000
Operating Expenses 1,250,590,000 1,092,842,000 1,102,173,000
Operating Income 1,128,337,000 1,097,128,000 876,432,000
Interest Expense 31,205,000 41,581,000 42,658,000
Income Before Tax 1,109,831,000 1,061,176,000 859,972,000
Income Tax Expense 221,964,000 216,134,000 180,883,000
Net Income 887,867,000 845,042,000 679,089,000
Per Share
EPS 10.77 10.17 8.12
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 288,266,000 453,932,000 112,546,000
Short Term Investments 0 0 0
Net Receivables 561,316,000 529,528,000 490,903,000
Inventory 381,877,000 380,282,000 367,823,000
Total Current Assets 1,399,897,000 1,495,254,000 1,044,229,000
Property Plant Equipment 829,252,000 817,676,000 768,092,000
Goodwill and Intangibles 516,776,000 450,461,000 459,467,000
Total Assets 3,293,443,000 3,259,925,000 2,746,765,000
Liabilities
Account Payables 114,211,000 110,643,000 110,221,000
Short Term Debt 439,326,000 344,799,000 674,407,000
Total Current Liabilities 1,067,916,000 951,547,000 1,235,803,000
Long Term Debt 547,622,000 722,554,000 694,387,000
Total Liabilities 1,698,130,000 1,775,395,000 2,138,027,999
Shareholders Equity
Retained Earnings 5,332,438,000 4,444,571,000 3,599,529,000
Total Shareholders Equity 1,595,313,000 1,484,530,000 608,737,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 288,266,000 453,932,000 112,546,000
Short Term Investments 0 0 0
Net Receivables 561,316,000 529,528,000 490,903,000
Inventory 381,877,000 380,282,000 367,823,000
Total Current Assets 1,399,897,000 1,495,254,000 1,044,229,000
Property Plant Equipment 829,252,000 817,676,000 768,092,000
Goodwill and Intangibles 516,776,000 450,461,000 459,467,000
Total Assets 3,293,443,000 3,259,925,000 2,746,765,000
Liabilities
Account Payables 114,211,000 110,643,000 110,221,000
Short Term Debt 439,326,000 344,799,000 674,407,000
Total Current Liabilities 1,067,916,000 951,547,000 1,235,803,000
Long Term Debt 547,622,000 722,554,000 694,387,000
Total Liabilities 1,698,130,000 1,775,395,000 2,138,027,999
Shareholders Equity
Retained Earnings 5,332,438,000 4,444,571,000 3,599,529,000
Total Shareholders Equity 1,595,313,000 1,484,530,000 608,737,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income 887,867,000 845,042,000 679,089,000
Depreciation & Amortization 129,936,000 114,908,000 111,900,000
Stock Based Compensation 60,295,000 59,739,000 49,770,000
Change in Working Capital -133,238,000 -72,429,000 -273,530,000
Operating Cash Flow 929,001,000 906,510,000 542,549,000
Investing Activities
Capital Expenditure -130,922,000 -133,631,000 -158,838,000
Investments -120,922,000 -133,631,000 -158,838,000
Investing Cash Flow -207,062,000 -125,254,000 -195,350,000
Financing Activities
Debt Repayment -75,000,000 -404,000,000 -430,500,000
Common Stock Issued/Repurchased -792,542,000 -71,920,000 -783,964,000
Dividends Paid 0 0 0
Financing Cash Flow -878,073,000 -441,996,000 -370,501,000
Summary
Free Cash Flow 798,079,000 772,879,000 383,711,000
Net Change in Cash -165,666,000 341,386,000 -31,908,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income 887,867,000 845,042,000 679,089,000
Depreciation & Amortization 129,936,000 114,908,000 111,900,000
Stock Based Compensation 60,295,000 59,739,000 49,770,000
Change in Working Capital -133,238,000 -72,429,000 -273,530,000
Operating Cash Flow 929,001,000 906,510,000 542,549,000
Investing Activities
Capital Expenditure -130,922,000 -133,631,000 -158,838,000
Investments -120,922,000 -133,631,000 -158,838,000
Investing Cash Flow -207,062,000 -125,254,000 -195,350,000
Financing Activities
Debt Repayment -75,000,000 -404,000,000 -430,500,000
Common Stock Issued/Repurchased -792,542,000 -71,920,000 -783,964,000
Dividends Paid 0 0 0
Financing Cash Flow -878,073,000 -441,996,000 -370,501,000
Summary
Free Cash Flow 798,079,000 772,879,000 383,711,000
Net Change in Cash -165,666,000 341,386,000 -31,908,000